Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis.

Fereig, Salma A; El-Zaafarany, Ghada M; Arafa, Mona G; Abdel-Mottaleb, Mona M A

Fereig, Salma A; El-Zaafarany, Ghada M; Arafa, Mona G; Abdel-Mottaleb, Mona M A.

Afiliação

Fereig SA; Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, The British University in Egypt (BUE), El Sherouk City, Egypt.
El-Zaafarany GM; Faculty of Pharmacy, Department of pharmaceutics and Industrial Pharmacy, Ain Shams University, Cairo, Egypt.
Arafa MG; Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, The British University in Egypt (BUE), El Sherouk City, Egypt.
Abdel-Mottaleb MMA; Chemotherapeutic Unit, Mansoura University Hospitals, Mansoura, Egypt.

Drug Deliv ; 27(1): 662-680, 2020 Dec.

Article em En | MEDLINE | ID: mdl-32393082

Assuntos

Anti-Inflamatórios/administração & dosagem; Portadores de Fármacos/química; Nanopartículas/química; Psoríase/tratamento farmacológico; Pele/efeitos dos fármacos; Anti-Inflamatórios/farmacocinética; Anti-Inflamatórios/uso terapêutico; Humanos; Psoríase/imunologia; Pele/imunologia; Absorção Cutânea/efeitos dos fármacos

Palavras-chave

Hybrid; lipid; metal; polymers; psoriasis; topical

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Pele / Portadores de Fármacos / Nanopartículas / Anti-Inflamatórios Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google